SNWV Sanuwave Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SNWV

Price (delayed)

$15.53

Market cap

$133.54M

P/E Ratio

8.35

Dividend/share

N/A

EPS

$1.86

Enterprise value

$144.93M

?
Relative Growth: Rel. Growth: 78
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: 94
Relative Profitability: Rel. Profitability: 69

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. ...

Highlights
The net income has surged by 146% year-on-year and by 36% since the previous quarter
Sanuwave Health's EPS has surged by 128% YoY and by 35% QoQ
The quick ratio has declined by 5% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://sanuwave.com
Peers: ABT MDT BDX ISRG

Key stats

What are the main financial stats of SNWV

SNWV stock price

How has the Sanuwave Health stock price performed over time
Intraday
-0.45%
1 week
-6.78%
1 month
-0.7%
1 year
-42.48%
YTD
-47.96%
QTD
-10.18%

Financial performance

How have Sanuwave Health's revenue and profit performed over time
Revenue
$44.33M
Gross profit
$34.02M
Operating income
$2.84M
Net income
$16.05M
Gross margin
76.7%
Net margin
36.2%
The net income has surged by 146% year-on-year and by 36% since the previous quarter
Sanuwave Health's net margin has soared by 138% YoY and by 35% from the previous quarter
Sanuwave Health's operating margin has plunged by 58% YoY and by 43% from the previous quarter
The operating income has contracted by 48% YoY and by 43% from the previous quarter

Price vs fundamentals

How does SNWV's price correlate with its fundamentals

Growth

What is Sanuwave Health's growth rate over time

Valuation

What is Sanuwave Health stock price valuation
P/E
8.35
P/B
72.62
P/S
3.01
EV/EBIT
6.88
EV/EBITDA
6.47
EV/Sales
3.27
Sanuwave Health's EPS has surged by 128% YoY and by 35% QoQ
The equity has surged by 111% year-on-year and by 14% since the previous quarter
The stock's P/S is 50% below its last 4 quarters average of 6.0
SNWV's revenue is up by 23% YoY

Efficiency

How efficient is Sanuwave Health business performance
Sanuwave Health's return on sales has surged by 176% YoY and by 15% QoQ
SNWV's return on assets has surged by 134% year-on-year and by 30% since the previous quarter
The ROIC has contracted by 44% from the previous quarter

Dividends

What is SNWV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SNWV.

Financial health

How did Sanuwave Health financials performed over time
Sanuwave Health's total assets is 5% higher than its total liabilities
Sanuwave Health's total liabilities has decreased by 27% YoY
Sanuwave Health's total assets has increased by 20% YoY
The equity has surged by 111% year-on-year and by 14% since the previous quarter
Sanuwave Health's debt has decreased by 18% YoY and by 3.5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.